Apex Biotechnology Financials
| 1733 Stock | TWD 33.80 0.20 0.59% |
Apex |
Understanding current and past Apex Biotechnology Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Apex Biotechnology's financial statements are interrelated, with each one affecting the others. For example, an increase in Apex Biotechnology's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Apex Biotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Apex Biotechnology Corp. Check Apex Biotechnology's Beneish M Score to see the likelihood of Apex Biotechnology's management manipulating its earnings.
Apex Biotechnology Stock Summary
Apex Biotechnology competes with Grape King, Standard Chemical, China Steel, and Sinphar Pharmaceutical. Apex Biotechnology Corp. engages in the research, development, manufacture, and sale of medical devices by using biosensor technology worldwide. Apex Biotechnology Corp. was founded in 1997 and is headquartered in Hsinchu, Taiwan. APEX BIOTECHNOLOGY operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan Stock Exchange |
| ISIN | TW0001733004 |
| Business Address | No 7, Li-Hsin |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.apexbio.com |
| Phone | 886 3 564 1952 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Apex Biotechnology without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Apex Stock, because this is throwing your money away. Analyzing the key information contained in Apex Biotechnology's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Apex Biotechnology Key Financial Ratios
There are many critical financial ratios that Apex Biotechnology's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Apex Biotechnology Corp reports annually and quarterly.| Return On Equity | 0.13 | |||
| Return On Asset | 0.0434 | |||
| Target Price | 76.45 | |||
| Number Of Employees | 17 | |||
| Beta | 0.36 |
Apex Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Apex Biotechnology's current stock value. Our valuation model uses many indicators to compare Apex Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Apex Biotechnology competition to find correlations between indicators driving Apex Biotechnology's intrinsic value. More Info.Apex Biotechnology Corp is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.34 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Apex Biotechnology Corp is roughly 2.95 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Apex Biotechnology's earnings, one of the primary drivers of an investment's value.Apex Biotechnology Corp Systematic Risk
Apex Biotechnology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Apex Biotechnology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Apex Biotechnology Corp correlated with the market. If Beta is less than 0 Apex Biotechnology generally moves in the opposite direction as compared to the market. If Apex Biotechnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Apex Biotechnology Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Apex Biotechnology is generally in the same direction as the market. If Beta > 1 Apex Biotechnology moves generally in the same direction as, but more than the movement of the benchmark.
Apex Biotechnology Thematic Clasifications
Apex Biotechnology Corp is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
| Biotech | View |
Apex Biotechnology March 25, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Apex Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Apex Biotechnology Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Apex Biotechnology Corp based on widely used predictive technical indicators. In general, we focus on analyzing Apex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Apex Biotechnology's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.16 | |||
| Information Ratio | 0.2896 | |||
| Maximum Drawdown | 7.17 | |||
| Value At Risk | (1.00) | |||
| Potential Upside | 2.29 |
Additional Tools for Apex Stock Analysis
When running Apex Biotechnology's price analysis, check to measure Apex Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apex Biotechnology is operating at the current time. Most of Apex Biotechnology's value examination focuses on studying past and present price action to predict the probability of Apex Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apex Biotechnology's price. Additionally, you may evaluate how the addition of Apex Biotechnology to your portfolios can decrease your overall portfolio volatility.